Isamu Horikoshi

1.5k citations
127 papers · 1.2k indexed · h-index 20
Topics
Nanoparticle-Based Drug Delivery (20 papers)Drug Transport and Resistance Mechanisms (14 papers)Analytical Methods in Pharmaceuticals (10 papers)
Partner nations
JapanChinaUnited States

In The Last Decade

Isamu Horikoshi

116 papers receiving 1.2k citations

Peers

Isamu Horikoshi
Comparison fields: 5 of 124
  • Molecular Biology 410
  • Biomaterials 396
  • Biomedical Engineering 240
  • Pharmaceutical Science 210
  • Oncology 192
Replace Doo-Man Oh with:
Doo-Man Oh United States
Reza Oliyai United States
Toshikiro Kimura Japan
Jouko Savolainen Finland
Hanna Kumpulainen Finland
Roberto Canaparo Italy
Hea‐Young Cho South Korea
Masahiro Sakagami Japan
Xin Yao China
Wen-Bin Shen China
Isamu Horikoshi relative to Doo-Man Oh United States Doo-Man Oh's profile →
Citations per field
00.5×1.5×1.9×
Doo-Man Oh · 1×
Citations per year

Countries citing papers authored by Isamu Horikoshi

Since Specialization
Citations

This map shows the geographic impact of Isamu Horikoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isamu Horikoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isamu Horikoshi more than expected).

Fields of papers citing papers by Isamu Horikoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isamu Horikoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isamu Horikoshi. The network helps show where Isamu Horikoshi may publish in the future.

Co-authorship network of co-authors of Isamu Horikoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Isamu Horikoshi. A scholar is included among the top collaborators of Isamu Horikoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isamu Horikoshi. Isamu Horikoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 16
4 36
5
Rectal Absorption of a 5-HT_3 Receptor Antagonist, Ondansetron, from a Suppository Containing a Tablet in Rabbits
1
6
In Vitro and In Vivo Evaluation of Chitosan Microspheres Containing Cisplatin : Hepatic Artery Chemo-embolization in Dogs
0
7 2
8 94
9 52
10 1
11 1
12 17
13 1
14 1
15 2
16 1
17 1
18 2
19 5
20 1

About Isamu Horikoshi

Isamu Horikoshi is a scholar working on Pharmaceutical Science, Pharmacology and Biomaterials, having authored 127 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (20 papers), Drug Transport and Resistance Mechanisms (14 papers) and Analytical Methods in Pharmaceuticals (10 papers). The work is most often cited by research in Pharmaceutical Science (210 citations), Biomaterials (396 citations) and Pharmacology (115 citations). Isamu Horikoshi has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Isao Adachi, Hitoshi Sato, Masaharu Ueno, Kenji Tazawa, Ekapop Viroonchatapan, Kiyoshi Konishi, Noriaki Takeguchi, Hitoshi Sato, N Sakuragawa and Keiji Sekiguchi. Their work appears in journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and Journal of Membrane Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026